Alyeska Investment Group
BIOA

Alyeska Investment Group’s BioAge Labs BIOA Stock Holding History

Alyeska Investment Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31M Buy
+75,000
New +$1.44M ﹤0.01% 565
2024
Q4 		– Sell
-150,000
Closed -$3.12M – 684
2024
Q3 		$3.12M Buy
+150,000
New +$3.01M 0.02% 387

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Alyeska Investment Group's BIOA Position: Q1 2026 in Review

Alyeska Investment Group opened a new position in BioAge Labs (BIOA) in Q1 2026: 75,000 shares worth $1.31M. The stake represents ﹤0.01% of the portfolio and ranks #565 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in BIOA as recently as Q3 2024.

Alyeska Investment Group first reported a position in BIOA in Q3 2024 and has held it in 2 quarters since. The position peaked at $3.12M in Q3 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Alyeska Investment Group held 75,000 shares of BioAge Labs worth $1.31M as of Q1 2026.
  • BioAge Labs was a new Alyeska Investment Group position in Q1 2026.
  • BioAge Labs made up ﹤0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #565 holding.
  • Alyeska Investment Group first reported a position in BioAge Labs in Q3 2024 and has held it in 2 quarters since.
  • Alyeska Investment Group's BioAge Labs position peaked at $3.12M in Q3 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.